Zobrazeno 1 - 10
of 37
pro vyhledávání: '"Lal Mohan, Kundu"'
Autor:
Nibedita Ghosh, Lal Mohan Kundu
Publikováno v:
European Journal of Medicinal Chemistry Reports, Vol 12, Iss , Pp 100236- (2024)
Cyclic peptides are an important class of bioactive molecules used as drugs as well as biomolecular probes. Peptide cyclization under the physiological environment, without added chemicals or reagents, would be a highly useful technique for in situ a
Externí odkaz:
https://doaj.org/article/a096151f2fb849bb8a3417dc2336f4a5
Autor:
Aviti Katare, Shubham Kumar, Sukanya Kundu, Swapnil Sharma, Lal Mohan Kundu, Bishnupada Mandal
Publikováno v:
ACS Omega. 8:17511-17522
Publikováno v:
Journal of Biotechnology. 362:24-35
The growth-associated metabolites are produced during the exponential phase; however, this phase terminates due to substrate depletion or product inhibition. In the present study, a semicontinuous mode with a fill-and-draw strategy was applied to ext
Autor:
Lal Mohan Kundu, Nibedita Ghosh
Publikováno v:
Future Medicinal Chemistry. 13:1767-1794
Alzheimer’s disease (AD) is a progressive neurodegenerative disorder, for which blocking the early steps of extracellular misfolded amyloid-β (Aβ) aggregation is a promising therapeutic approach. However, the pathological features of AD progressi
Publikováno v:
Journal of Photochemistry and Photobiology A: Chemistry. 442:114776
Publikováno v:
ChemistrySelect. 6:3256-3261
Autor:
Aviti Katare, Swapnil Sharma, Himali Horo, Sourav Bhowmick, Lal Mohan Kundu, Bishnupada Mandal
Publikováno v:
Chemical Engineering Journal. 466:143215
Publikováno v:
Biomaterials Science Series ISBN: 9781839164989
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::89d2e09d9e358ede5de6922402aa8ffc
https://doi.org/10.1039/9781839166235-00497
https://doi.org/10.1039/9781839166235-00497
Publikováno v:
ChemistrySelect. 4:6778-6783
Publikováno v:
International Journal of Biological Macromolecules. 121:1070-1076
Controlled drug delivery offers improved therapeutic efficacy of the drugs while minimizing side effects. Biocompatible polymers and nanomaterials have emerged as effective carriers for the controlled delivery of drugs. We have synthesized a prodrug